TRANE-TECHNOLOGIES
16.11.2021 09:32:06 CET | Business Wire | Press release
Thermo King® , the transport refrigeration brand of global climate innovator Trane Technologies (NYSE: TT), today premiered its trailer refrigeration system with zero direct carbon emissions at the Solutrans international trade show in Lyon, France.
The Thermo King® AxlePower technology combines a fully electric refrigeration unit, highly efficient battery storage, and the ability to run on low or zero-emissions power sources, such as an axle energy recovery system, shore power or hybrid system. The sustainable battery enables the refrigeration unit to operate autonomously and keep the cargo at optimal temperature, even when the vehicle is not running.
“Safe, sustainable transport of foods, medicines and vaccines is more critical than ever,” said Francesco Incalza, president of Thermo King Europe, Middle East, and Africa. “Temperature-controlled transport is subject to the highest operational safety requirements. Our technology can ensure sensitive goods stay at the required temperature, while reducing energy, emissions, and noise – all important to a sustainable future. We’re proud to continue to deliver breakthrough technology, which supports our customers’ sustainability goals and our Gigaton Challenge to reduce customer carbon emissions by one gigaton by 2030.”
The new solution delivers immediate and long-term sustainability benefits while reducing operating costs. With zero direct emissions and silent operation, it enables inner-city deliveries, including in Ultra-low Emission Zones (ULEZs). Intelligent energy management ensures that there are always enough battery reserves, even on long journeys or in traffic jams. If necessary, the system can also harvest energy from the tractive power of the trailer. All components are monitored in real time by a Thermo King telematics system.
Thermo King will showcase the AxlePower zero-direct emission trailer refrigeration unit powered by BPW’s ePower system at the Solutrans international trade show , Nov. 16-20. Currently in the testing phase, this integrated system recovers energy generated when the vehicle is rolling, sailing or braking and stores it in Thermo King’s efficient battery to power the refrigeration system. This system is tractor-independent and compatible with all Thermo King trailer refrigeration units. The solution has been nominated from more than 100 applications as one of seven finalists for the Solutrans Innovation Award.
Also showcased at the event will be Thermo King’s E200 fully electric unit for small vans and trucks, and the new Advancer Hybrid refrigeration unit, the latest addition to the Advancer A-Series trailer range, which seamlessly switches between the primary electric operating mode to engine power when needed.
“At Trane Technologies, sustainability is at the centre of everything we do as we challenge what’s possible for the industry, and the world,” said Incalza. “For decades, Thermo King has led the industry in electrification of transport refrigeration, and we continue to relentlessly innovate in support of our customers, our communities and our planet.”
Thermo King has committed to invest more than $100 million over the next three years to deliver a fully-electric product in every segment of the cold chain by 2023 in EMEA and 2025 in the Americas.
With its 2030 Sustainability Commitments , Trane Technologies is helping solve for some of the world’s biggest sustainability challenges. These commitments include a pledge to reduce customer greenhouse gas emissions by one gigaton (2% of the world’s annual emissions) and achieve carbon-neutral operations. Its “Opportunity for All” pledge commits to achieving gender parity in leadership, workforce diversity reflective of its communities, and community initiatives that support equitable education and pathways to green and Science, Technology, Engineering and Math (STEM) careers.
About Thermo King
Thermo King – by Trane Technologies (NYSE: TT), a global climate innovator – is a worldwide leader in sustainable transport temperature control solutions. Thermo King has been providing transport temperature control solutions for a variety of applications, including trailers, truck bodies, buses, air, shipboard containers, and railway cars since 1938. For more information, visit www.thermoking.com
or www.europe.thermoking.com
.
About Trane Technologies
Trane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our environmentally responsible portfolio of products and services, we bring efficient and sustainable climate solutions to buildings, homes, and transportation. Learn more at tranetechologies.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005093/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Investor Supporting Japan’s Entertainment Industry, Yoshihiro Shimamura, to Visit France Workshop to be Held During the Cannes Film Festival28.4.2026 04:00:00 CEST | Press release
Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of Hankyu Hanshin Holdings, Inc.—a major Japanese entertainment conglomerate known for producing content enjoyed across generations—and became a major shareholder (as of March 25, 2026). Through such investments, the company aims to support the global expansion of Japanese entertainment while exploring synergies with its own interna
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom